Clinical Trials

Source: CCM

Score: 15
Phase 1 Cancers
An Open-Label Study of GV20-0251 in Patients With Advanced and/or Refractory Solid Tumor Malignancies
Score: 13
Phase 1 Cancers
Study of ARTS-021 in Patients With Advanced Solid Tumors
Score: 8
Phase 1 Cancers
A Phase 1 Study of ASP1002 in Participants With Metastatic or Locally Advanced Solid Tumors
Score: 7
Phase 1 Cancers
A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors
Score: 6
Phase 1 Cancers
A Phase 1 Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Anti-tumor Activity of PF-07248144 in Participants With Advanced or Metastatic Solid Tumors
Score: 5
Phase 1 Cancers
A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors
Score: 4
Phase 1 Cancers
Phase 1 First in Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-400 in Adult Subjects With Advanced Solid Tumors
Score: 3
Phase 1 Cancers
Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors and Lymphomas
Score: 2
Phase 1 Cancers
An Open-label, Dose Escalation, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Score: 1
Phase 1 Cancers
Phase I, First-in-human, Open-label, Dose Escalation Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of BNT152+153 in Patients With Solid Tumors